Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis.
Carrier M, Cameron C, Delluc A, Castellucci L, Khorana AA, Lee AY. Carrier M, et al. Among authors: castellucci l. Thromb Res. 2014 Dec;134(6):1214-9. doi: 10.1016/j.thromres.2014.09.039. Epub 2014 Oct 8. Thromb Res. 2014. PMID: 25457583 Review.
BACKGROUND: Current clinical practice guidelines all recommend the use of therapeutic doses of low molecular weight heparins (LMWH) for the initial and long-term treatment of cancer-related thrombosis. The use of vitamin-K antagonists (VKA) is acceptable if LMWH is not ava …
BACKGROUND: Current clinical practice guidelines all recommend the use of therapeutic doses of low molecular weight heparins (LMWH) for the …
Case-fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis.
Tritschler T, Patel A, Kraaijpoel N, Bhatt DL, De Luca G, Di Santo P, Feres F, Costa RA, Hibbert B, Isshiki T, Le Gal G, Castellucci LA. Tritschler T, et al. Among authors: castellucci la. Res Pract Thromb Haemost. 2022 Nov 4;6(7):e12834. doi: 10.1002/rth2.12834. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36349260 Free PMC article.
The CFR of major bleeding was 10.8% (95% confidence interval [CI], 7.1-16.2; I (2) = 50%) in the entire study population, and 13.8% (95% CI, 6.5-27.1; I (2) = 28%), 11.2% (95% CI, 6.7-18.0; I (2) = 0%), and 5.8% (95% CI, 3.0-11.1; I (2) = 0%) in those on short-term (6 mont …
The CFR of major bleeding was 10.8% (95% confidence interval [CI], 7.1-16.2; I (2) = 50%) in the entire study population, and 13.8% (95% CI, …
Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management.
Ge M, Ladha D, Lymer J, Pancic S, Carrier M, Le Gal G, Castellucci LA. Ge M, et al. Among authors: castellucci la. Res Pract Thromb Haemost. 2024 Mar 1;8(2):102357. doi: 10.1016/j.rpth.2024.102357. eCollection 2024 Feb. Res Pract Thromb Haemost. 2024. PMID: 38550529 Free PMC article.
BACKGROUND: Since administration of COVID-19 vaccines, there has been growing evidence of thrombotic and thrombocytopenic events following vaccination. However, there remains limited data on long-term management of these adverse hematologic events. KEY CLINICAL QUESTION: W …
BACKGROUND: Since administration of COVID-19 vaccines, there has been growing evidence of thrombotic and thrombocytopenic events following v …